InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
19,008.80
(
0.27%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.13
(
-0.17%
)
Bitcoin
60,712.38
(
0.75%
)
Post# of 5735
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Jukimol

Send PM Follow Ignore
Followers 23
Posts 602
Boards Moderated 0
Alias Born 01/19/2009

Jukimol

Re: The Rainmaker post# 2427

Saturday, 01/08/2011 6:13:54 PM

Saturday, January 08, 2011 6:13:54 PM

Post# of 5735
The problem with Biomoda is that they are having internal issues (CEO just stepped down which is 90% a sign that the ship is going down) and they have delayed results of phase II trials.

We're also comparing apples to oranges when you compare BMOD to RPC.. RPC test is FDA approved and it can detect 14 different types of tumors. You get what you pay for.

Biomoda has no sales or income not even a distribution mechanism.

Much riskier bet.

Shares of RPC dropped after the trading was halted- almost always happens as the market fgoes into a panic.

RPC is a much more stable and now debt free company with real orders, revenue and huge pending developments and good news flow.

Guaranteed shares will go higher on Monday. Especially if the company releases news as expecting.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up